Published in J Clin Endocrinol Metab on September 01, 1999
TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell (2001) 1.37
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol Ther (2008) 1.16
Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol (2001) 1.15
Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization. J Clin Endocrinol Metab (2014) 1.06
The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis. BMC Evol Biol (2008) 1.04
Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular Med (2005) 0.99
Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies. J R Soc Interface (2012) 0.88
Genetic variations in human G protein-coupled receptors: implications for drug therapy. AAPS PharmSci (2001) 0.86
International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors. Pharmacol Rev (2015) 0.83
A new form or a variant of SMD type A4. J Appl Genet (2012) 0.82
Molecular basis for skeletal variation: insights from developmental genetic studies in mice. Birth Defects Res B Dev Reprod Toxicol (2007) 0.78
Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia. J Clin Endocrinol Metab (2016) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature (1991) 7.98
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis (2005) 4.17
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (1994) 4.04
The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab (2001) 3.55
Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet (1997) 3.37
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A (1992) 3.01
A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science (1995) 2.78
Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci U S A (1997) 2.52
Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development (2000) 2.39
Kawasaki disease: recent advances. Arch Dis Child (1991) 2.30
SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet (1998) 2.30
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
Congenital lumbosacral lipomas. Childs Nerv Syst (1997) 2.11
Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child (2002) 2.11
Plasma renin activity and aldosterone concentration in children. Br Med J (1975) 2.03
X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet (1994) 1.97
Measurement of blood pressure in children. Recommendations of a working party of the British Hypertension Society. BMJ (1989) 1.95
Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet (1995) 1.88
Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. J Clin Endocrinol Metab (2001) 1.87
FGFR2 mutations in Pfeiffer syndrome. Nat Genet (1995) 1.82
Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int (2007) 1.70
Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child (1983) 1.64
Genitopatellar syndrome: a new condition comprising absent patellae, scrotal hypoplasia, renal anomalies, facial dysmorphism, and mental retardation. J Med Genet (2000) 1.62
A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab (1999) 1.61
Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61
Partial rescue of PTH/PTHrP receptor knockout mice by targeted expression of the Jansen transgene. Endocrinology (2001) 1.61
Acute renal failure complicating cardiopulmonary bypass surgery. Arch Dis Child (1982) 1.61
Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet (1997) 1.59
Toxic shock syndrome. Arch Dis Child (1985) 1.58
Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest (1986) 1.55
15-year follow-up of renin and blood pressure in reflux nephropathy. Lancet (1996) 1.55
Endothelial dysfunction late after Kawasaki disease. Circulation (1996) 1.53
Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84) Endocrinology (1995) 1.53
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest (1998) 1.52
Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int (2007) 1.51
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet (1996) 1.50
Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet (1997) 1.49
Sulphate transporter gene mutations in apparently isolated club foot. J Med Genet (2001) 1.47
The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol (1989) 1.46
Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients. Eur J Endocrinol (2014) 1.46
Plasma renin activity and aldosterone concentration in the human newborn. Arch Dis Child (1976) 1.45
The postnatal management of hydronephrosis diagnosed by prenatal ultrasound. J Urol (1990) 1.45
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int (2006) 1.45
Facial anomalies in D-2-hydroxyglutaric aciduria. Am J Med Genet (1999) 1.42
A gene for Meckel syndrome maps to chromosome 11q13. Am J Hum Genet (1998) 1.42
Receptors for PTH and PTHrP: their biological importance and functional properties. Am J Physiol (1999) 1.40
Long-term outcome of boys with posterior urethral valves. Br J Urol (1988) 1.40
Performance of a new blood pressure monitor in children and young adults: the difficulties in clinical validation. Blood Press (1998) 1.40
Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet (2001) 1.40
A new lethal syndrome of exomphalos, short limbs, and macrogonadism. J Med Genet (1999) 1.39
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38
Hypocalcaemic stridor in children. How often is it missed? Clin Pediatr (Phila) (1991) 1.38
Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet (2001) 1.37
Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology (1993) 1.36
Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. Arch Dis Child (1983) 1.35
Genetic study of scaphocephaly. Am J Med Genet (1996) 1.34
A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet (2001) 1.34
Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int (1992) 1.31
Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet (2001) 1.31
Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology (1993) 1.31
Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol (1997) 1.30
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet (1995) 1.27
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr (1988) 1.27
Epidemic neuromyasthenia: outbreak among nurses at a children's hospital. Br Med J (1974) 1.26
Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet (2003) 1.26
Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum (2004) 1.25
Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev (1998) 1.25
Proceedings: Plasma renin activity and aldosterone concentration in children. Arch Dis Child (1974) 1.19
Functional analysis of the PTH/PTHrP network of ligands and receptors. Recent Prog Horm Res (1998) 1.19
The measurement of blood pressure and the detection of hypertension in children and adolescents. J Hum Hypertens (2001) 1.19
Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction. J Biol Chem (1996) 1.18
Malnutrition in infants receiving cult diets: a form of child abuse. Br Med J (1979) 1.18
Autosomal recessive polycystic kidney disease. Pediatr Nephrol (1989) 1.18
COL9A3: A third locus for multiple epiphyseal dysplasia. Am J Hum Genet (1999) 1.17
Clinical, radiological, and chondro-osseous findings in opsismodysplasia: survey of a series of 12 unreported cases. J Med Genet (2003) 1.16
A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab (1998) 1.16
Clinical variability in patients with Apert's syndrome. J Neurosurg (1999) 1.15
Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol Metab (2001) 1.15
Antineutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child (1989) 1.15
Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol (2001) 1.15
Craniometaphyseal and craniodiaphyseal dysplasia, head and neck manifestations and management. J Laryngol Otol (1996) 1.15
Crescentic glomerulonephritis in children. Pediatr Nephrol (1992) 1.14
Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet (1996) 1.14
Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy. Q J Med (1979) 1.14
Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol (1995) 1.12
Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ (1991) 1.12
The molecular basis of X-linked spondyloepiphyseal dysplasia tarda. Am J Hum Genet (2001) 1.12
Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet (2001) 1.11
Measurement and interpretation of blood pressure. Arch Dis Child (2000) 1.11
Hypertension, oedema, and suppressed renin aldosterone system due to unsupervised salt administration. Arch Dis Child (1975) 1.10
Measurement of plasma renin activity by semi-micro radioimmunoassay of generated angiotensin I. J Clin Pathol (1975) 1.10
Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma? Blood Press (2000) 1.09
Atypical findings in Kabuki syndrome: report of 8 patients in a series of 20 and review of the literature. Am J Med Genet A (2004) 1.08